Roche announces US Food and Drug Administration approval of Xofluza (baloxavir marboxil) for influenza

Roche announces US Food and Drug Administration approval of Xofluza (baloxavir marboxil) for influenza

PDF(888 KB)

PDF(888 KB)

Chinese Journal of Infection and Chemotherapy ›› 2020, Vol. 20 ›› Issue (1) : 112-112.

Information Exchange

Roche announces US Food and Drug Administration approval of Xofluza (baloxavir marboxil) for influenza

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 20(1): 112-112

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(888 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉